Vistagen Therapeutics (VTGN) Revenue (2017 - 2025)
Historic Revenue for Vistagen Therapeutics (VTGN) over the last 11 years, with Q4 2025 value amounting to $303000.0.
- Vistagen Therapeutics' Revenue rose 2948.72% to $303000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $790000.0, marking a year-over-year increase of 1879.7%. This contributed to the annual value of $486000.0 for FY2025, which is 5432.33% down from last year.
- Per Vistagen Therapeutics' latest filing, its Revenue stood at $303000.0 for Q4 2025, which was up 2948.72% from $258000.0 recorded in Q3 2025.
- In the past 5 years, Vistagen Therapeutics' Revenue ranged from a high of $893000.0 in Q3 2022 and a low of -$15000.0 during Q1 2025
- For the 5-year period, Vistagen Therapeutics' Revenue averaged around $273805.0, with its median value being $251000.0 (2025).
- Per our database at Business Quant, Vistagen Therapeutics' Revenue soared by 35128.21% in 2023 and then plummeted by 10914.63% in 2025.
- Quarter analysis of 5 years shows Vistagen Therapeutics' Revenue stood at $358000.0 in 2021, then crashed by 49.72% to $180000.0 in 2022, then surged by 128.33% to $411000.0 in 2023, then plummeted by 43.07% to $234000.0 in 2024, then increased by 29.49% to $303000.0 in 2025.
- Its last three reported values are $303000.0 in Q4 2025, $258000.0 for Q3 2025, and $244000.0 during Q2 2025.